187 related articles for article (PubMed ID: 11899952)
1. Vitamin D and vitamin D analogs in cancer treatment.
van den Bemd GJ; Chang GT
Curr Drug Targets; 2002 Feb; 3(1):85-94. PubMed ID: 11899952
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D analogs and breast cancer.
O'Kelly J; Koeffler HP
Recent Results Cancer Res; 2003; 164():333-48. PubMed ID: 12899532
[TBL] [Abstract][Full Text] [Related]
4. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
[TBL] [Abstract][Full Text] [Related]
5. The role of vitamin D in prostate cancer.
Krishnan AV; Peehl DM; Feldman D
Recent Results Cancer Res; 2003; 164():205-21. PubMed ID: 12899524
[TBL] [Abstract][Full Text] [Related]
6. Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer.
Leyssens C; Verlinden L; Verstuyf A
Endocr Relat Cancer; 2013 Apr; 20(2):R31-47. PubMed ID: 23319494
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D and cancer: an update of in vitro and in vivo data.
Ordonez-Moran P; Larriba MJ; Pendas-Franco N; Aguilera O; Gonzalez-Sancho JM; Munoz A
Front Biosci; 2005 Sep; 10():2723-49. PubMed ID: 15970529
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effects of 1,25-dihydroxyvitamin D3 and vitamin D analogs.
van den Bemd GJ; Pols HA; van Leeuwen JP
Curr Pharm Des; 2000 May; 6(7):717-32. PubMed ID: 10828303
[TBL] [Abstract][Full Text] [Related]
9. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
Chiang KC; Chen SC; Yeh CN; Pang JH; Shen SC; Hsu JT; Liu YY; Chen LW; Kuo SF; Takano M; Kittaka A; Sun CC; Juang HH; Chen TC
J Steroid Biochem Mol Biol; 2014 Jan; 139():54-60. PubMed ID: 24125734
[TBL] [Abstract][Full Text] [Related]
10. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG
Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529
[TBL] [Abstract][Full Text] [Related]
12. Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: role of the direct inhibition of CYP24 enzyme activity.
Swami S; Krishnan AV; Peehl DM; Feldman D
Mol Cell Endocrinol; 2005 Sep; 241(1-2):49-61. PubMed ID: 15955619
[TBL] [Abstract][Full Text] [Related]
13. New vitamin D analogs.
Slatopolsky E; Finch J; Brown A
Kidney Int Suppl; 2003 Jun; (85):S83-7. PubMed ID: 12753273
[TBL] [Abstract][Full Text] [Related]
14. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
Barreto AM; Schwartz GG; Woodruff R; Cramer SD
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):265-70. PubMed ID: 10750664
[TBL] [Abstract][Full Text] [Related]
15. [Immune modulation by vitamin D analogs in the prevention of autoimmune diseases].
Bouillon R; Verstuyf A; Branisteanu D; Waer M; Mathieu C
Verh K Acad Geneeskd Belg; 1995; 57(5):371-85; discussion 385-7. PubMed ID: 8571669
[TBL] [Abstract][Full Text] [Related]
16. Osteoblast differentiation and control by vitamin D and vitamin D metabolites.
van Driel M; Pols HA; van Leeuwen JP
Curr Pharm Des; 2004; 10(21):2535-55. PubMed ID: 15320744
[TBL] [Abstract][Full Text] [Related]
17. 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.
Zhao XY; Peehl DM; Navone NM; Feldman D
Endocrinology; 2000 Jul; 141(7):2548-56. PubMed ID: 10875257
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a vitamin D3-resistant MCF-7 cell line.
Narvaez CJ; Vanweelden K; Byrne I; Welsh J
Endocrinology; 1996 Feb; 137(2):400-9. PubMed ID: 8593782
[TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
20. Effect of vitamin D metabolites and analogs on renal and intestinal calbindin-D in the rat.
Hemmingsen C; Staun M; Lewin E; Nielsen PK; Olgaard K
Calcif Tissue Int; 1996 Nov; 59(5):371-6. PubMed ID: 8849404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
